Overview
Ketazolam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. Ketazolam is not approved in Canada or America.
Indication
Ketazolam could be used for the treatment of anxiety. In approved countries, it is indicated for the treatment of anxiety, tension, irritability and similar stress related symptoms.
Associated Conditions
- Anxiety
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| LOFTRAN CAP 30MG | smithkline beecham pharma division of smithkline beecham inc | 01919520 | Capsule - Oral | 30 MG / CAP | 12/31/1992 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| KETAZOLAM ADAMED 15 mg CAPSULAS DURAS | Adamed Laboratorios S.L.U. | 56259 | CÁPSULA DURA | Medicamento Sujeto A Prescripción Médica. Psicótropos | Commercialized |
| KETAZOLAM ADAMED 45 mg CAPSULAS DURAS | Adamed Laboratorios S.L.U. | 56261 | CÁPSULA DURA | Medicamento Sujeto A Prescripción Médica. Psicótropos | Commercialized |
| KETAZOLAM ADAMED 30 mg CAPSULAS DURAS | Adamed Laboratorios S.L.U. | 56260 | CÁPSULA DURA | Medicamento Sujeto A Prescripción Médica. Psicótropos | Commercialized |
| SEDOTIME 30 mg CAPSULAS DURAS | 56234 | CÁPSULA DURA | Medicamento Sujeto A Prescripción Médica. Psicótropos | Commercialized | |
| SEDOTIME 45 mg CAPSULAS DURAS | 56271 | CÁPSULA DURA | Medicamento Sujeto A Prescripción Médica. Psicótropos | Commercialized | |
| SEDOTIME 15 mg CAPSULAS DURAS | 56235 | CÁPSULA DURA | Medicamento Sujeto A Prescripción Médica. Psicótropos | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.